Search
Xenpozyme supply update for the ASMD community
ANPDF shares the latest Xenpozyme supply update from INPDA and Sanofi, including where Australian families can check current information. If you have concerns about treatment or supply, please contact your specialist team.
ANPDF
4d2 min read
Xenpozyme Listed on LSDP for Niemann-Pick ASMD (Type A/B and Type B)
Xenpozyme® (olipudase alfa) has been listed on the Life Saving Drugs Program (LSDP) for patients with Acid Sphingomyelinase Deficiency (ASMD).
ANPDF
Oct 2, 20252 min read
Pfrieger's Digest | Issue 14 - May – August 2025
Frank W. Pfrieger, PhD Summaries of latest research advances related to Niemann-Pick diseases, acid sphingomyelinase deficiency (ASMD)...
ANPDF
Sep 25, 20252 min read
Pfrieger's Digest | Issue 12 - August 2024 – December 2024
Summaries of latest research advances related to Niemann-Pick diseases, acid sphingomyelinase deficiency (ASMD) and Niemann-Pick type C...
ANPDF
Jan 21, 20251 min read